Hematology & Oncology
Credentials: Degree: MD 2002 · Identifier: NPI 1821130550 · License: MD
Hematology and Medical Oncology
University of Maryland School of Medicine
Internal Medicine
Tulane University School of Medicine
Doctor of Medicine
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Journal of Clinical Oncology · 2015 · 478 citations
Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin
Clinical Cancer Research · 2010 · 54 citations
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
Clinical Cancer Research · 2023 · 48 citations
Richard Pazdur
3 papers
Paul Kluetz
2 papers
Bethany Sleckman
1 paper
Daniel Catenacci
Deirdre Cohen
Edward Sausville
Hedy Kindler
Heinz-Josef Lenz
James Wallace
Lakshmi Rajdev
Marc Theoret
Mark Kozloff
